The prostate cancer research team I lead at Southampton has been having fantastic success in recent years. We have been contributing to trials that are really making a difference.
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale.
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
Background: Clinically significant nonmetastatic prostate cancer (PCa) is currently treated using whole-gland therapy. This approach is effective but can have urinary, sexual, and rectal side effects.
A new audio series brought to you by The Focal Therapy Clinic, where our host, Clare Delmar, explores some issues facing men diagnosed with prostate cancer that are little known, less understood and almost never talked about.
Consultant Urologist Tim Dudderidge discusses the stages in the imaging-led prostate cancer diagnostic pathway, and outlines what patients need to know.